Ceftazidime Supplier-Buyer Network — Trade Flow Analysis

Name: Ceftazidime Supplier-Buyer Trade Network Dataset — 228+ Indian Exporters, 14+ Importers, 99+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Ceftazidime supplier network, Ceftazidime buyers, pharmaceutical export India, Ceftazidime trade data

TransData Nexus

Ceftazidime

India Pharmaceutical Trade Intelligence

$10.7M228 Suppliers99 CountriesHS 30042019

ExportsIndia → GHANA19.5%India → UKRAINE14.3%

ImportsITALY → India$52.7M BELGIUM → India$327.7K

Who Supplies Ceftazidime? Top Manufacturers & Buyers 2026 — ZEISS PHARMACEUTICALS PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1ZEISS PHARMACEUTICALS PRIVATE LIMITED

ZEISS PHARMACEUTICALS PRIVATE LIMITED is the first-largest Ceftazidime exporter from India, with a market share of 19.4% and a total export value of $2.1M across 8 shipments. Their average shipment value of $258.3K is above the market average of $11.6K, suggesting premium or bulk contract pricing.

ZEISS PHARMACEUTICALS PRIVATE LIMITED serves 4 named buyers in our database. OA&J PHARMACEUTICALS LTD. is the dominant customer, accounting for 97.5% of this supplier's tracked business. Top customers include:

• OA&J PHARMACEUTICALS LTD. — $2.0M across 8 shipments (97.5% of this supplier's total exports)

• OA&J PHARMACEUTICALS LTD. — $36.4K across 0 shipments (1.8% of this supplier's total exports)

• OA & J PHARMACEUTICA — $8.1K across 0 shipments (0.4% of this supplier's total exports)

• OA&J PHARMACEUTICALS LTD. — $8.1K across 0 shipments (0.4% of this supplier's total exports)

Key Insight: ZEISS PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $258.3K is 2127% above the market average of $11.6K, consistent with large-order contracts or value-added formulations.

2ANANTA MEDICARE LIMITED

ANANTA MEDICARE LIMITED is the second-largest Ceftazidime exporter from India, with a market share of 9.6% and a total export value of $1.0M across 21 shipments. Their average shipment value of $48.9K is above the market average of $11.6K, suggesting premium or bulk contract pricing.

ANANTA MEDICARE LIMITED serves 3 named buyers in our database. ANANTA MEDICARE UKRAINE LIMITED is the dominant customer, accounting for 62.9% of this supplier's tracked business. Top customers include:

• ANANTA MEDICARE UKRAINE LIMITED — $645.5K across 13 shipments (62.9% of this supplier's total exports)

• ANANTA MEDICARE UKRAINE LIMITED — $362.0K across 7 shipments (35.3% of this supplier's total exports)

• MEDINOVA PHARMACEUTI — $18.4K across 0 shipments (1.8% of this supplier's total exports)

Key Insight: ANANTA MEDICARE LIMITED's per-shipment value of $48.9K is 321% above the market average of $11.6K, consistent with large-order contracts or value-added formulations.

3VENUS REMEDIES LIMITED

VENUS REMEDIES LIMITED is the third-largest Ceftazidime exporter from India, with a market share of 4.6% and a total export value of $487.0K across 73 shipments. Their average shipment value of $6.7K is below the market average of $11.6K, reflecting a high-volume, competitive pricing strategy.

VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• E P H K — $174.3K across 26 shipments (35.8% of this supplier's total exports)

• V P G — $137.7K across 21 shipments (28.3% of this supplier's total exports)

• I S P L — $84.5K across 13 shipments (17.3% of this supplier's total exports)

• P C L — $45.4K across 7 shipments (9.3% of this supplier's total exports)

• MINISTRY OF HEALTH S — $45.0K across 7 shipments (9.2% of this supplier's total exports)

Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (73 shipments) at a per-shipment value of $6.7K, indicating a broad distribution network with many smaller, regular orders.

4BIOCOLL PHARMACEUTICALS PRIVATE LIMITED

BIOCOLL PHARMACEUTICALS PRIVATE LIMITED is the fourth-largest Ceftazidime exporter from India, with a market share of 1.9% and a total export value of $201.3K across 4 shipments. Their average shipment value of $50.3K is above the market average of $11.6K, suggesting premium or bulk contract pricing.

BIOCOLL PHARMACEUTICALS PRIVATE LIMITED serves 1 named buyer in our database. BIOMEDIC HEALTHCARE SOLUTION is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• BIOMEDIC HEALTHCARE SOLUTION — $201.3K across 4 shipments (100.0% of this supplier's total exports)

Key Insight: BIOCOLL PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $50.3K is 334% above the market average of $11.6K, consistent with large-order contracts or value-added formulations.

5SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI

SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI is the fifth-largest Ceftazidime exporter from India, with a market share of 1.7% and a total export value of $176.5K across 12 shipments. Their average shipment value of $14.7K is above the market average of $11.6K, suggesting premium or bulk contract pricing.

SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI serves 3 named buyers in our database. TO THE DIRECTOR OF is the dominant customer, accounting for 56.9% of this supplier's tracked business. Top customers include:

• TO THE DIRECTOR OF — $100.5K across 7 shipments (56.9% of this supplier's total exports)

• TO THE DIRECTOR OF — $69.0K across 5 shipments (39.1% of this supplier's total exports)

• TO THE DIRECTOR — $7.0K across 0 shipments (4.0% of this supplier's total exports)

Key Insight: SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI's per-shipment value of $14.7K is 27% above the market average of $11.6K, consistent with large-order contracts or value-added formulations.

6THEON PHARMACEUTICALS LIMITED

THEON PHARMACEUTICALS LIMITED is the fifth-largest Ceftazidime exporter from India, with a market share of 1.0% and a total export value of $103.8K across 23 shipments. Their average shipment value of $4.5K is below the market average of $11.6K, reflecting a high-volume, competitive pricing strategy.

THEON PHARMACEUTICALS LIMITED serves 4 named buyers in our database. SYNER-MED PHARMACEUT is the dominant customer, accounting for 59.7% of this supplier's tracked business. Top customers include:

• SYNER-MED PHARMACEUT — $62.0K across 14 shipments (59.7% of this supplier's total exports)

• SYNER-MED PHARMACEUT — $27.5K across 6 shipments (26.4% of this supplier's total exports)

• GREEN CORE PHARMA IN — $7.6K across 2 shipments (7.3% of this supplier's total exports)

• GREEN CORE PHARMA IN — $6.8K across 2 shipments (6.6% of this supplier's total exports)

Key Insight: THEON PHARMACEUTICALS LIMITED operates with high shipment frequency (23 shipments) at a per-shipment value of $4.5K, indicating a broad distribution network with many smaller, regular orders.

1Ghana

Ghana ranks as the first-largest destination for Ceftazidime imports from India, with a total trade value of $2.1M across 3 shipments — representing a 19.5% share of all Ceftazidime exports. The average shipment value of $694.5K is above the global average of $11.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ceftazidime importers in Ghana: OA&J PHARMACEUTICALS LTD. is the largest buyer, accounting for 97.2% ($2.0M) of this market's total imports.

• OA&J PHARMACEUTICALS LTD. — $2.0M (97.2% of Ghana's total)

Key Insight: Ghana's per-shipment average of $694.5K (5887% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ghana is a key market for Ceftazidime imports from India.

Primary Market

Secondary Market

2Ukraine

Ukraine ranks as the second-largest destination for Ceftazidime imports from India, with a total trade value of $1.5M across 18 shipments — representing a 14.3% share of all Ceftazidime exports. The average shipment value of $84.8K is above the global average of $11.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Ceftazidime importers in Ukraine: ANANTA MEDICARE UKRAINE LTD. is the largest buyer, accounting for 78.9% ($1.2M) of this market's total imports.

• ANANTA MEDICARE UKRAINE LTD. — $1.2M (78.9% of Ukraine's total)

• ANANTA MEDICARE UKRAINE LIMITED — $362.0K (23.7% of Ukraine's total)

Key Insight: Ukraine's per-shipment average of $84.8K (631% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ukraine is a key market for Ceftazidime imports from India.

Primary Market

Secondary Market

3Sudan

Sudan ranks as the third-largest destination for Ceftazidime imports from India, with a total trade value of $850.9K across 3 shipments — representing a 8.0% share of all Ceftazidime exports. The average shipment value of $283.6K is above the global average of $11.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ceftazidime importers in Sudan: TO THE DIRECTOR OF is the largest buyer, accounting for 11.8% ($100.5K) of this market's total imports.

• TO THE DIRECTOR OF — $100.5K (11.8% of Sudan's total)

Key Insight: Sudan's per-shipment average of $283.6K (2345% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sudan is a key market for Ceftazidime imports from India.

Primary Market

Secondary Market

4France

France ranks as the fourth-largest destination for Ceftazidime imports from India, with a total trade value of $416.6K across 17 shipments — representing a 3.9% share of all Ceftazidime exports. The average shipment value of $24.5K is above the global average of $11.6K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Ceftazidime importers in France: PLANETPHARMA SA is the largest buyer, accounting for 31.0% ($129.0K) of this market's total imports.

• PLANETPHARMA SA — $129.0K (31.0% of France's total)

• DISTRIMEX. — $95.0K (22.8% of France's total)

• DISTRIMEX PARC LOGISTIQUE DU PONT DE — $91.5K (22.0% of France's total)

Key Insight: France's per-shipment average of $24.5K (111% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Ceftazidime imports from India.

Primary Market

Secondary Market

5Myanmar

Myanmar ranks as the fifth-largest destination for Ceftazidime imports from India, with a total trade value of $397.4K across 4 shipments — representing a 3.7% share of all Ceftazidime exports. The average shipment value of $99.3K is above the global average of $11.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ceftazidime importers in Myanmar: BIOMEDIC HEALTHCARE SOLUTION is the largest buyer, accounting for 50.7% ($201.3K) of this market's total imports.

• BIOMEDIC HEALTHCARE SOLUTION — $201.3K (50.7% of Myanmar's total)

Key Insight: Myanmar's per-shipment average of $99.3K (757% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Myanmar is a key market for Ceftazidime imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ceftazidime.
2.Flow Mapping: 228 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 920 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 99 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

920 Verified Shipments

228 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Ceftazidime

Ceftazidime

Who Supplies Ceftazidime? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Ceftazidime? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Ceftazidime Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1ZEISS PHARMACEUTICALS PRIVATE LIMITED

2ANANTA MEDICARE LIMITED

3VENUS REMEDIES LIMITED

4BIOCOLL PHARMACEUTICALS PRIVATE LIMITED

5SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI

6THEON PHARMACEUTICALS LIMITED

From Indian Factories to Global Pharmacies — How Ceftazidime Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Ceftazidime Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Ghana

2Ukraine

3Sudan

4France

5Myanmar

People Also Ask — Ceftazidime Supplier & Trade Network

Ceftazidime Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology